BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 990 filers reported holding BAXTER INTL INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $665 | -24.9% | 17,631 | -9.4% | 0.08% | -21.0% |
| Q2 2023 | $886 | -54.3% | 19,468 | -59.3% | 0.10% | -56.2% |
| Q1 2023 | $1,940 | -27.3% | 47,837 | -8.6% | 0.24% | -30.8% |
| Q4 2022 | $2,668 | -99.9% | 52,357 | +4.5% | 0.35% | -10.6% |
| Q3 2022 | $2,697,000 | -13.4% | 50,087 | +3.3% | 0.39% | -7.0% |
| Q2 2022 | $3,114,000 | -14.7% | 48,497 | +3.0% | 0.42% | +3.2% |
| Q1 2022 | $3,650,000 | -10.8% | 47,082 | -1.3% | 0.40% | -4.9% |
| Q4 2021 | $4,094,000 | +5.5% | 47,700 | -1.2% | 0.42% | -4.9% |
| Q3 2021 | $3,882,000 | +7.4% | 48,275 | +7.5% | 0.45% | +6.9% |
| Q2 2021 | $3,616,000 | -4.9% | 44,923 | -0.4% | 0.42% | -10.1% |
| Q1 2021 | $3,803,000 | +5.1% | 45,092 | +0.0% | 0.46% | -1.1% |
| Q4 2020 | $3,617,000 | +5.5% | 45,082 | +5.8% | 0.47% | -5.4% |
| Q3 2020 | $3,427,000 | -5.0% | 42,624 | +1.8% | 0.50% | -15.3% |
| Q2 2020 | $3,606,000 | +3.2% | 41,882 | -2.7% | 0.59% | -13.0% |
| Q1 2020 | $3,495,000 | -4.5% | 43,056 | -1.6% | 0.68% | +21.4% |
| Q4 2019 | $3,660,000 | +0.3% | 43,771 | +4.9% | 0.56% | -6.1% |
| Q3 2019 | $3,649,000 | +6.0% | 41,721 | -0.8% | 0.59% | +6.5% |
| Q2 2019 | $3,443,000 | +2.6% | 42,046 | +1.9% | 0.56% | -2.8% |
| Q1 2019 | $3,356,000 | +19.2% | 41,281 | -3.5% | 0.57% | +3.1% |
| Q4 2018 | $2,816,000 | -13.9% | 42,776 | +0.8% | 0.56% | +0.4% |
| Q3 2018 | $3,270,000 | +3.3% | 42,426 | -1.0% | 0.55% | -3.5% |
| Q2 2018 | $3,165,000 | +12.0% | 42,876 | -1.4% | 0.57% | +9.8% |
| Q1 2018 | $2,827,000 | -0.3% | 43,476 | -0.9% | 0.52% | +2.0% |
| Q4 2017 | $2,835,000 | +0.8% | 43,861 | -2.1% | 0.51% | -3.2% |
| Q3 2017 | $2,812,000 | +2.5% | 44,820 | -1.1% | 0.53% | -2.0% |
| Q2 2017 | $2,744,000 | +14.7% | 45,340 | -1.8% | 0.54% | +9.8% |
| Q1 2017 | $2,393,000 | +8.1% | 46,155 | -7.6% | 0.49% | +2.5% |
| Q4 2016 | $2,214,000 | -6.7% | 49,950 | +0.2% | 0.48% | -9.3% |
| Q3 2016 | $2,374,000 | -3.3% | 49,875 | -8.1% | 0.53% | -8.2% |
| Q2 2016 | $2,454,000 | +4.6% | 54,275 | -5.0% | 0.58% | +1.9% |
| Q1 2016 | $2,346,000 | +11.3% | 57,131 | -3.8% | 0.56% | +3.5% |
| Q4 2015 | $2,108,000 | +5.9% | 59,413 | -2.0% | 0.55% | +3.2% |
| Q3 2015 | $1,991,000 | -53.2% | 60,612 | -0.4% | 0.53% | -50.3% |
| Q2 2015 | $4,255,000 | -6.3% | 60,856 | -8.2% | 1.06% | -7.4% |
| Q1 2015 | $4,540,000 | -4.6% | 66,275 | +2.1% | 1.15% | -8.1% |
| Q4 2014 | $4,757,000 | +5.3% | 64,920 | +3.2% | 1.25% | -2.0% |
| Q3 2014 | $4,516,000 | -1.1% | 62,925 | -24.3% | 1.28% | -3.5% |
| Q2 2014 | $4,567,000 | -1.6% | 83,168 | +31.9% | 1.32% | -8.1% |
| Q1 2014 | $4,641,000 | +19.8% | 63,068 | +13.2% | 1.44% | +16.1% |
| Q4 2013 | $3,875,000 | +7.8% | 55,728 | +1.9% | 1.24% | -0.7% |
| Q3 2013 | $3,593,000 | -7.5% | 54,703 | -2.5% | 1.25% | -11.3% |
| Q2 2013 | $3,885,000 | – | 56,098 | – | 1.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |